NeuBase Therapeutics, Inc.
USD0.38
-0.01 (-1.56%)
CEO
Todd P. Branning
IPO Date
2004-05-28
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$0.38
Prev. Close
$0.38
Day Low
$0.36
Day High
$0.39
52W Low
$0.36
52W High
$4.44
Market Cap
$0.00B
Volume
0.09M
| -3.8 |
| 30 Sept 2020 | FY | 0.0% | 0.0% | -55.2% | -50.1% | 0.00 | 10.42 | -8.6 |
| 30 Sept 2019 | FY | 0.0% | 0.0% | -270.1% | -216.2% | 0.01 | 4.41 | -1.5 |
| 30 Sept 2018 | FY | 0.0% | 0.0% | -121.4% | -113.9% | 0.01 | 5.52 | -0.8 |
| 30 Sept 2017 | FY | 0.0% | 0.0% | -104.2% | -85.3% | 0.00 | 2.64 | -1.4 |
| 30 Sept 2016 | FY | 0.0% | 0.0% | -103.2% | -87.5% | 0.00 | 2.96 | -3.4 |
| 30 Sept 2015 | FY | 0.0% | 0.0% | -35.8% | -32.8% | 0.00 | 7.48 | -5.2 |
| 30 Sept 2014 | FY | 0.0% | 0.0% | -34.1% | -28.5% | 0.00 | 2.53 | -5.9 |
| 30 Sept 2013 | FY | 0.0% | 0.0% | -107.4% | -98.4% | 0.00 | 10.77 | -8.9 |
| -0.2 |
| 31 Mar 2023 | Q2 | 0.0% | 0.0% | -28.3% | -19.1% | 0.39 | 7.40 | -0.4 |
| 31 Dec 2022 | Q1 | 0.0% | 0.0% | -24.0% | -17.1% | 0.32 | 8.37 | -0.4 |
| 30 Sept 2022 | Q4 | 0.0% | 0.0% | -32.9% | -23.3% | 0.26 | 5.92 | -0.4 |
| 30 Jun 2022 | Q3 | 0.0% | 0.0% | -28.0% | -21.2% | 0.20 | 7.53 | -1.0 |
| 31 Mar 2022 | Q2 | 0.0% | 0.0% | -26.0% | -20.3% | 0.17 | 8.07 | -1.5 |
| 31 Dec 2021 | Q1 | 0.0% | 0.0% | -16.4% | -13.5% | 0.13 | 11.69 | -3.0 |
| 30 Sept 2021 | Q4 | 0.0% | 0.0% | -13.2% | -11.2% | 0.12 | 13.10 | -4.1 |
| 30 Jun 2021 | Q3 | 0.0% | 0.0% | -14.4% | -12.5% | 0.11 | 19.18 | -4.2 |